Showing 231-240 of 355 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Assessment of a Tolerogenic Nanoparticle in a Humanized Mouse Islet Transplantation Model | Northwestern University | Jacqueline Burke | Cures | 01-April-2024 to 30-June-2027 | $499,746.76 |
| Validation of a Tolerogenic Nanotherapy for Islet Transplantation in a Non-Human Primate Model | Northwestern University | Jacqueline Burke | Cures | 01-July-2023 to 30-June-2027 | $1,066,627.41 |
| A New Preparation of the Intact Eye for Measurements of Retinal Dysfunction in Acute Hyperglycemia and Early Diabetes | Northwestern University | Gregory Schwartz | Improving Lives | 01-October-2023 to 01-November-2027 | $406,927.40 |
| Differential Aptalyzer: a wearable hydrogel microneedle platform for continuous monitoring of C-peptide in vivo | New York University | Mahla Poudineh | Cures | 01-November-2026 to 31-October-2029 | $997,957.86 |
| GPR75, a novel actor in beta cell regeneration | New York Medical College | Ercument Dirice | Cures | 01-April-2022 to 31-March-2027 | $750,000.00 |
| Transdisciplinary Care for Young Adults with Type 1 Diabetes Transitioning to Adult Healthcare | Nemours Children’s Clinic | Jessica Pierce | Improving Lives | 01-May-2023 to 30-April-2028 | $640,819.87 |
| Evaluating the Impact of High-Risk HLA-DR Serotypes on the Cellular Neighborhood of the Pancreatic Islets: Towards Early Identification of T1D Disease Risk and Prevention | Missouri University of Science and Technology | Gina Yosten | Cures | 01-October-2025 to 30-September-2028 | $740,097.60 |
| T1D Data Identification Consensus Initiative | Milliman | Rebecca Smith | Cures | 15-September-2026 to 31-May-2027 | $260,000.00 |
| Multicolor cellular immunoimaging of response to transplanted islet cells | Michigan State University | Bryan Smith | Cures | 01-June-2023 to 31-May-2026 | $750,000.00 |
| Autoimmune stem-like T cells in type 1 diabetes | Memorial Sloan-Kettering Cancer Center | Andrea Schietinger | Cures | 01-September-2023 to 31-August-2026 | $750,000.00 |